GLYXAMBI
Live / Registered — Registered — international registration renewed (as of 06 May 2024)
What this means for you
Registered since 24 Sept 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79129593
- Registration number
- 4405329
- Mark type
- Stylized text
- Filed
- 20 Mar 2013
- Published for opposition
- 09 Jul 2013
- Registered
- 24 Sept 2013
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of [ the alimentary tract and ] metabolism [, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders ]
Owner
Prosecution history
- 06 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 06 May 2024 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 16 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Aug 2023 — TEAS SECTION 71 & 15 RECEIVED
- 06 Jan 2023 — INTERNATIONAL REGISTRATION RENEWED
- 24 Sept 2022 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 20 Dec 2019 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 06 Nov 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 06 Nov 2019 — INVALIDATION PROCESSED
- 19 Oct 2019 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 19 Feb 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 19 Feb 2019 — REGISTERED-SEC.71 ACCEPTED
- 19 Feb 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Feb 2019 — TEAS SECTION 71 RECEIVED
- 16 Nov 2013 — NOTIFICATION PROCESSED BY IB